logo
ENTITY

InflaRx NV (IFRX US)

9
Analysis
Health Care • United States
InflaRx N.V. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops monoclonal antibodies drugs for the treatment of inflammatory diseases. InflaRx serves patients worldwide.
more
Exchange Announcement • 29 Jun 2024 04:56

424B5 | Prospectus

Exchange Announcement • 25 Jan 2024 21:00

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 05 Jan 2024 05:16

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 06 Nov 2023 21:00

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Exchange Announcement • 01 Nov 2023 20:04

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 (PDF)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x